Eli Lilly and Company has formed a strategic partnership with DKSH to distribute its pharmaceutical products in Macau.
4 reports, 1 independent
Updated Jul 6
Gone quiet
Reached 4 outlets in its first 24 hours
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eli Lilly and Company has formed a strategic partnership with DKSH to distribute its pharmaceutical products in Macau.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
-
Macau
city and special administrative region of China
-
DKSH
company
Nothing else this week.
Related events
- Eli Lilly and Company entered a strategic partnership with Twist Bioscience Corporation regarding data provision and services.
- Eli Lilly and Company announced agreements to acquire potential targets, filing reports with the SEC.
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
- Eli Lilly captured market share from Novo Nordisk in the weight loss drug sector.
- Lilly and Novo Nordisk are competing in the weight loss drug market, with Lilly expanding its US market coverage.